Cigna Investments’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $404K | Hold |
767
| – | – | 0.05% | 296 |
|
|
2026
Q1 | $431K | Sell |
767
-18
| -2% | -$11.5K | 0.07% | 262 |
|
|
2025
Q4 | $532K | Hold |
785
| – | – | 0.08% | 224 |
|
|
2025
Q3 | $502K | Hold |
785
| – | – | 0.07% | 239 |
|
|
2025
Q2 | $421K | Sell |
785
-32
| -4% | -$15.3K | 0.07% | 263 |
|
|
2025
Q1 | $343K | Sell |
817
-26
| -3% | -$11.3K | 0.06% | 294 |
|
|
2024
Q4 | $349K | Sell |
843
-14
| -2% | -$6.14K | 0.06% | 304 |
|
|
2024
Q3 | $433K | Sell |
857
-10
| -1% | -$4.86K | 0.08% | 252 |
|
|
2024
Q2 | $423K | Sell |
867
-9
| -1% | -$4.52K | 0.08% | 241 |
|
|
2024
Q1 | $473K | Hold |
876
| – | – | 0.09% | 224 |
|
|
2023
Q4 | $487K | Sell |
876
-17
| -2% | -$7.98K | 0.1% | 210 |
|
|
2023
Q3 | $391K | Sell |
893
-121
| -12% | -$60.3K | 0.09% | 237 |
|
|
2023
Q2 | $509K | Buy |
1,014
+15
| +2% | +$7.19K | 0.09% | 210 |
|
|
2023
Q1 | $501K | Sell |
999
-30
| -3% | -$14.4K | 0.1% | 209 |
|
|
2022
Q4 | $420K | Buy |
1,029
+10
| +1% | +$3.88K | 0.09% | 252 |
|
|
2022
Q3 | $332K | Sell |
1,019
-57
| -5% | -$20.9K | 0.07% | 292 |
|
|
2022
Q2 | $378K | Sell |
1,076
-416
| -28% | -$170K | 0.08% | 271 |
|
|
2022
Q1 | $816K | Sell |
1,492
-440
| -23% | -$231K | 0.1% | 194 |
|
|
2021
Q4 | $1.27M | Sell |
1,932
-735
| -28% | -$461K | 0.1% | 163 |
|
|
2021
Q3 | $1.66M | Sell |
2,667
-115
| -4% | -$77.3K | 0.12% | 147 |
|
|
2021
Q2 | $1.76M | Sell |
2,782
-318
| -10% | -$176K | 0.13% | 146 |
|
|
2021
Q1 | $1.52M | Sell |
3,100
-7
| -0.2% | -$3.51K | 0.1% | 170 |
|
|
2020
Q4 | $1.55M | Buy |
3,107
+344
| +12% | +$154K | 0.12% | 151 |
|
|
2020
Q3 | $1.09M | Sell |
2,763
-1,390
| -33% | -$514K | 0.1% | 173 |
|
|
2020
Q2 | $1.37M | Sell |
4,153
-781
| -16% | -$226K | 0.13% | 152 |
|
|
2020
Q1 | $1.2M | Buy |
4,934
+422
| +9% | +$110K | 0.15% | 148 |
|
|
2019
Q4 | $1.22M | Buy |
4,512
+1,830
| +68% | +$482K | 0.13% | 206 |
|
|
2019
Q3 | $764K | Buy |
2,682
+200
| +8% | +$55.7K | 0.08% | 295 |
|
|
2019
Q2 | $700K | Sell |
2,482
-78
| -3% | -$19.2K | 0.08% | 299 |
|
|
2019
Q1 | $573K | Buy |
2,560
+22
| +0.9% | +$4.54K | 0.06% | 348 |
|
|
2018
Q4 | $473K | Sell |
2,538
-53
| -2% | -$10.9K | 0.04% | 348 |
|
|
2018
Q3 | $550K | Sell |
2,591
-289
| -10% | -$70.2K | 0.04% | 340 |
|
|
2018
Q2 | $627K | Sell |
2,880
-911
| -24% | -$188K | 0.05% | 354 |
|
|
2018
Q1 | $726K | Sell |
3,791
-2,681
| -41% | -$495K | 0.05% | 333 |
|
|
2017
Q4 | $1.01M | Sell |
6,472
-132
| -2% | -$20.8K | 0.07% | 245 |
|
|
2017
Q3 | $1.03M | Sell |
6,604
-15
| -0.2% | -$2.37K | 0.07% | 238 |
|
|
2017
Q2 | $1.07M | Sell |
6,619
-1,737
| -21% | -$282K | 0.07% | 231 |
|
|
2017
Q1 | $1.29M | Buy |
8,356
+4,980
| +148% | +$686K | 0.09% | 207 |
|
|
2016
Q4 | $396K | Buy |
+3,376
| New | +$385K | 0.04% | 468 |
|
Other funds holding IDXX
Cigna Investments's IDXX Position: Q2 2026 in Review
Cigna Investments held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 767 shares worth $404K. The position accounts for 0.05% of the portfolio, ranked #296.
Cigna Investments first reported a position in IDXX in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.76M in Q2 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Cigna Investments held 767 shares of Idexx Laboratories worth $404K as of Q2 2026.
- Cigna Investments left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up 0.05% of Cigna Investments's portfolio in Q2 2026, its #296 holding.
- Cigna Investments first reported a position in Idexx Laboratories in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Idexx Laboratories position peaked at $1.76M in Q2 2021.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.